Cellular therapies represent a new frontier in the treatment of neurological disease.
Mesenchymal stem cells (MSCs), which can be harvested from bone marrow, adipose …

Neurological disorders are a massive challenge for modern medicine. Apart from the fact
that this group of diseases is the second leading cause of death worldwide, the majority of …

Mesenchymal stem cells (MSCs) have been proposed as an alternative therapy to be
applied into several pathologies of the nervous system. These cells can be obtained from …

Mesenchymal Stem Cells or Marrow Stromal Cells (MSCs) have long been viewed as a
potent tool for regenerative cell therapy. MSCs are easily accessible from both healthy donor …

Neurological disorders are recognized as major causes of death and disability worldwide.
Because of this, they represent one of the largest public health challenges. With awareness …

Mesenchymal stem cells/marrow stromal cells (MSCs) present a promising tool for cell
therapy, and are currently being tested in US FDA-approved clinical trials for myocardial …

Phase I clinical trials exploring the use of autologous mesenchymal stem cell (MSC) therapy
for the treatment of multiple sclerosis (MS) have begun in a number of centers across the …

Over the past few decades, the application of mesenchymal stem cells has captured the
attention of researchers and practitioners worldwide. These cells can be obtained from …

Multiple sclerosis (MS) is a multifocal inflammatory disease that involves the central nervous
system and associated with limbs paralysis and serious problems in sensation, limbs, visual …

Bone marrow-derived mesenchymal stem cells (MSCs) are attractive candidates for use in
regenerative medicine since they are easily accessible and can be readily expanded in vivo …